Suppr超能文献

D-环丝氨酸不能增强强迫症的暴露反应预防疗法。

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

作者信息

Storch Eric A, Merlo Lisa J, Bengtson Michael, Murphy Tanya K, Lewis Mark H, Yang Mark C, Jacob Marni L, Larson Michael, Hirsh Adam, Fernandez Melanie, Geffken Gary R, Goodman Wayne K

机构信息

Departments of Psychiatry, University of Florida, Florida 32610, USA.

出版信息

Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. doi: 10.1097/YIC.0b013e32819f8480.

Abstract

Obsessive-compulsive disorder is a common, chronic, and oftentimes disabling disorder. The only established first-line treatments for obsessive-compulsive disorder are exposure and response prevention therapy and the serotonin reuptake inhibitors. Many patients do not experience complete symptom resolution with either modality and require augmentation approaches. Recent animal and clinical data suggest that D-cycloserine, a partial agonist that acts at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate receptor complex, may enhance extinction learning that occurs in exposure-based psychotherapies. Given this, this study examined if D-cycloserine (250 mg) enhances the overall efficacy and rate of change of exposure and response prevention therapy for adult obsessive-compulsive disorder. Participants were 24 adults meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria for obsessive-compulsive disorder. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining exposure and response prevention therapy+D-cycloserine versus exposure and response prevention therapy+placebo. All patients received 12 weekly sessions of exposure and response prevention treatment. The first session involved building a ritual hierarchy and providing psychoeducation about obsessive-compulsive disorder. The second session involved a practice exposure. Sessions 3-12 involved exposure and response prevention exercises. D-cycloserine or placebo (250 mg) was taken 4 h before every session. No significant group differences were found across outcome variables. The rate of improvement did not differ between groups. The present results fail to support the use of D-cycloserine with exposure and response prevention therapy for adult obsessive-compulsive disorder. As this study is the first to explore this question and a number of methodological issues must be considered when interpreting the findings, the conclusions that may be drawn from our results are limited.

摘要

强迫症是一种常见的慢性疾病,常常导致功能障碍。强迫症唯一已确立的一线治疗方法是暴露与反应预防疗法以及5-羟色胺再摄取抑制剂。许多患者使用这两种方法中的任何一种都无法完全缓解症状,因此需要辅助治疗方法。最近的动物和临床数据表明,D-环丝氨酸是一种作用于N-甲基-D-天冬氨酸受体复合物中对士的宁不敏感的甘氨酸识别位点的部分激动剂,可能会增强基于暴露的心理治疗中的消退学习。鉴于此,本研究检验了D-环丝氨酸(250毫克)是否能提高成人强迫症暴露与反应预防疗法的总体疗效和变化率。研究对象为24名符合《精神障碍诊断与统计手册》第四版强迫症标准的成年人。研究设计为随机、双盲、安慰剂对照的辅助试验,比较暴露与反应预防疗法+D-环丝氨酸与暴露与反应预防疗法+安慰剂的效果。所有患者均接受为期12周的暴露与反应预防治疗。第一节课包括建立仪式等级制度并提供有关强迫症的心理教育。第二节课进行一次练习暴露。第3至12节课进行暴露与反应预防练习。在每节课前4小时服用D-环丝氨酸或安慰剂(250毫克)。在各项结果变量上未发现显著的组间差异。两组的改善率没有差异。目前的结果不支持将D-环丝氨酸与暴露与反应预防疗法联合用于成人强迫症治疗。由于本研究是首次探讨这个问题,在解释研究结果时必须考虑一些方法学问题,因此从我们的结果中得出的结论是有限的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验